Archives: Drug Cards

Restoril Restoril is the brand name for temazepam, a short‑to‑intermediate–acting benzodiazepine widely prescribed for the short‑term treatment of insomnia. Its pharmacologic profile, dosing conventions, and safety considerations are summarized below…

Restasis Restasis (cyclosporine ophthalmic emulsion 0.05%) is the first FDA‑approved topical immunomodulator for the treatment of ocular surface inflammation. --- Mechanism of Action Cyclosporine A blocks the protease calcium‑dependent phosphatase…

Requip Requip (generic: pramipexole) is a non‑ergoline dopamine agonist widely used in movement disorders and for the treatment of restless legs syndrome. Mechanism of Action Selectively stimulates dopamine D₃ receptors…

Repatha Mechanism of Action Repatha (alirocumab) is a fully human, monoclonal IgG₂ antibody that selectively binds proprotein convertase subtilisin/kexin type 9 (PCSK9). By neutralizing PCSK9, it prevents the proteolytic degradation…

Repaglinide Repaglinide is a short‑acting, non‑sulfonylurea oral hypoglycemic that stimulates insulin release from pancreatic β‑cells. It is primarily used for glycaemic control in patients with type 2 diabetes mellitus (T2DM), particularly…

Renvela Renvela --- Mechanism of Action Renvela is a selective antagonist of the renal cell epithelial sodium channel (ENaC) and angiotensin‑II type 1 receptor (AT1R). ENaC blockade ↓ sodium reabsorption…

Renflexis Renflexis (palmitoylethanolamide) is a topical non‑steroidal analgesic approved for chronic neuropathic pain. It delivers a potent anti‑inflammatory lipid mediator directly to affected peripheral nerves. Mechanism of Action Palmitoylethanolamide (PEA)…

Remicade Mechanism of Action Remicade (infliximab) is a chimeric monoclonal antibody that binds both soluble and membrane‑bound TNF‑α (tumor necrosis factor‑α). Neutralization of TNF‑α → ↓ inflammatory cytokine signaling. Induction…

Remeron Mechanism of Action Remeron (mirtazapine) is a noradrenergic‑selective antagonist and specific inhibitor of serotonin reuptake. Increases norepinephrine (NE) by blocking presynaptic α₂‑adrenergic autoreceptors. Enhances serotonin (5‑HT) release through 5‑HT₂/5‑HT₃…

Relugolix Relugolix is an orally‑administered gonadotropin‑releasing hormone (GnRH) antagonist used in the management of prostate cancer, endometriosis, and uterine fibroids. It provides rapid androgen or estrogen suppression without the initial…